RMD.AX · RESMED INC
Australia · RS rating 83 · As of 2026-10-14
| Price | 33.58 AUD |
|---|---|
| 1-day change | -0.0% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 86 / 83 / 52 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 37 / 38 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | -3.6% |
| Sales growth Q/Q | +2.2% |
| Distance from 52-week high | +18.8% |
| Market cap (USD) | $31.9B |